产品名称

英文名称：Olmutinib

同义词

Olmutinib、1353550-13-6、HM61713、1802181-20-9、BI 1482694、Olmutinib [INN]、HM-61713、Olmutinib [WHO-DD]、BI-1482694、HM-61713 (BI-1482694)、N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide、CHL9B67L95、N-(3-((2-((4-(4-

产品性质

CAS编号：1353550-13-6

分子式：C26H26N6O2S

分子量：486.59

PubChem编号：54758501

英文别名：Olmutinib|1353550-13-6|HM61713|1802181-20-9|BI 1482694|Olmutinib [INN]|HM-61713|Olmutinib [WHO-DD]|BI-1482694|HM-61713 (BI-1482694)|N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide|CHL9B67L95|N-(3-((2-((4-(4-

规格或纯度：97%

英文名称：Olmutinib

储存温度：-20°C储存

运输条件：超低温冰袋运输

产品介绍：产品介绍Olmutinib (BI 1482694) 是一种新型的EGFR突变特效性酪氨酸激酶抑制剂、布鲁顿氏酪氨酸激酶抑制剂。

ALogP：4.7

IUPAC Name：N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide

INCHI：InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)

InChi Key：FDMQDKQUTRLUBU-UHFFFAOYSA-N

Canonical SMILES：CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4

Isomeric SMILES：CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4

PubChem CID：54758501

CAS Registry No.：1353550-13-6

DrugCentral Ligand：5210

溶解性：insoluble in H2O; ≥9.11 mg/mL in EtOH with ultrasonic; ≥96.6 mg/mL in DMSO

象形图：

信号词：Warning

危险声明：H315 Causes skin irritationH319 Causes serious eye irritationH335 May cause respiratory irritationH301 Toxic if swallowed

预防措施声明：P261,P305+P351+P338

产品包装